Kura Oncology (KURA) Analyst & Key Data

Analyst Consensus

Buy13 analysts

Buy

Updated Sep 12, 2026

Total Analysts13

Buy

15

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score4.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$11.39

Median Target+124.23%

$25.54

Potential upside vs current price

DCF Value+46.41%

$16.68

Potential upside vs current price

Current Stock Price

$11.39

Median Target+124.23%

$25.54

Potential upside vs current price

DCF Value+46.41%

$16.68

Potential upside vs current price

Analyst Consensus

Buy13 analysts

Buy

Updated Sep 12, 2026

Total Analysts13

Buy

15

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score4.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$11.39

Median Target+124.23%

$25.54

Potential upside vs current price

DCF Value+46.41%

$16.68

Potential upside vs current price

Current Stock Price

$11.39

Median Target+124.23%

$25.54

Potential upside vs current price

DCF Value+46.41%

$16.68

Potential upside vs current price

Kura Oncology, Inc.